The Single Best Strategy To Use For AS2863619
The principal goal of this study was to examine the position of glutaminase inhibition as a method to deal with adaptive resistance to IR in head and neck most cancers. The combination of glutaminase inhibition with telaglenastat and IR was when compared with the effects of impartial treatment alone in clonogenic assays and in two xenograft designs